Symrise AG

SY1

DE000SYM9999

Specialty Chemicals

Market Closed - Xetra Other stock markets 11:35:20 2024-07-17 EDT			5-day change	1st Jan Change
111.2 ^EUR	-1.33%		-2.33%	+11.65%

07-17	SYMRISE AG : Berenberg reaffirms its Neutral rating	ZD
07-15	SYMRISE AG : Receives a Buy rating from UBS	ZD

SYMRISE AG : UBS gives a Buy rating

January 10, 2023 at 02:14 am

In a research note published by Charles Eden, UBS advises its customers to buy the stock. The target price is set at 122 versus 123 EUR.

Latest news about Symrise AG

SYMRISE AG : Berenberg reaffirms its Neutral rating	07-17	ZD
SYMRISE AG : Receives a Buy rating from UBS	07-15	ZD
SYMRISE AG : Buy rating from Deutsche Bank	07-05	ZD
SYMRISE AG : Receives a Buy rating from JP Morgan	07-04	ZD
New semester, new state of mind	07-01
SYMRISE AG : Goldman Sachs maintains a Sell rating	07-01	ZD
SYMRISE AG : Jefferies maintains a Buy rating	07-01	ZD
UBS raises target for Symrise to 134 euros - 'Buy'	06-26	DP
SYMRISE AG : UBS reiterates its Buy rating	06-26	ZD
SYMRISE AG : Baader Bank maintains a Buy rating	06-24	ZD
EU fines IFF for obstructing investigation of suspected fragrance cartel	06-24	RE
SYMRISE AG : Barclays sticks Neutral	06-20	ZD
JPMorgan raises target for Symrise - 'Positive Catalyst Watch' status	06-18	DP
SYMRISE AG : JP Morgan maintains a Buy rating	06-18	ZD
SYMRISE AG : Receives a Buy rating from Deutsche Bank	06-14	ZD
Dpa-AFX Overview: COMPANIES from 12.06.2024 15:15	06-12	DP
New Symrise CEO wants to drive profitability	06-12	DP
Dsm-firmenich sees boost as weight-loss drugs spur healthier choices	06-10	RE
Deutsche Bank sees potential in Symrise - share in demand	05-28	DP
European shares waver as euro zone consumers lower inflation expectation	05-28	RE
Deutsche Bank raises Symrise to 'Buy' - target up to 120 euros	05-28	DP
Symrise up thanks to buy recommendation - consolidates six-week high	05-28	DP
SYMRISE AG : From Neutral to Buy by Deutsche Bank	05-28	ZD
European shares struggle for direction ahead of ECB's inflation surveys	05-28	RE
Europe's STOXX 600 hits record high on earnings, rate cut optimism	05-10	RE

Symrise AG is one of the world's leaders in developing, producing and marketing scents, flavors and functional ingredients. Net sales break down by family of products as follows: - nutritional ingredients (63%): for use in the manufacture of food products (beverages, candies, chocolates, cereals, dairy products, snacks, sauces, instant noodles, etc.) and in the manufacture of animal and fish feed; - perfumes and flavours (37%): perfumes, menthols, aromatic ingredients and chemicals for personal care products, oral care products, cleaning products, cosmetics, etc. Net sales are distributed geographically as follows: Germany (8.1%), Europe/Middle East/Africa (31.6%), the United States (24.4%), North America (2.1%), Asia/Pacific (20.7%) and Latin America (13.1%).

Sector

Specialty Chemicals

Calendar

2024-08-01 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Ratings for Symrise AG

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

111.2 EUR

Average target price

117.3 EUR

Spread / Average Target

+5.46%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
SYMRISE AG	+11.65%	17B
ECOLAB INC.	+22.67%	69.48B
SIKA AG	-4.09%	47.58B
GIVAUDAN SA	+21.04%	43.96B
FUJIFILM HOLDINGS CORPORATION	+35.50%	29.4B
EMS-CHEMIE HOLDING AG	+5.51%	18.99B
CELANESE CORPORATION	-6.12%	15.93B
POSCO FUTURE M CO., LTD.	-31.20%	13.86B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-32.02%	11.69B
NITTO DENKO CORPORATION	+27.35%	12B

Other Specialty Chemicals

Symrise AG

Equities

SY1

DE000SYM9999

Specialty Chemicals

SYMRISE AG : UBS gives a Buy rating

Latest news about Symrise AG

Chart Symrise AG

Company Profile

Income Statement Evolution

Ratings for Symrise AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Specialty Chemicals